BCG
LLY icon

BayBridge Capital Group’s Eli Lilly LLY Stock Holding History

BayBridge Capital Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-684
Closed -$528K – 105
2024
Q4 		$528K Buy
684
+2
+0.3% +$1.66K 0.38% 64
2024
Q3 		$604K Sell
682
-40
-6% -$36K 0.44% 56
2024
Q2 		$653K Buy
722
+19
+3% +$15.2K 0.51% 49
2024
Q1 		$514K Sell
703
-82
-10% -$58.4K 0.45% 51
2023
Q4 		$504K Buy
+785
New +$458K 0.47% 50

Other funds holding LLY

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BayBridge Capital Group's LLY Position: Q1 2025 in Review

BayBridge Capital Group sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 684 shares — an estimated $528K sold.

BayBridge Capital Group first reported a position in LLY in Q4 2023 and held it in 5 quarters. The position peaked at $653K in Q2 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • BayBridge Capital Group reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • BayBridge Capital Group sold 684 Eli Lilly shares in Q1 2025, an estimated $528K.
  • BayBridge Capital Group first reported a position in Eli Lilly in Q4 2023 and held it in 5 quarters.
  • BayBridge Capital Group's Eli Lilly position peaked at $653K in Q2 2024.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on BayBridge Capital Group's 13F filing for Q1 2025, filed 17 Apr 2025.